+
LANXESS Lewatit MDS TP 108 Removes Short-Chain PFAS from Water
ECONOMY & POLICY

LANXESS Lewatit MDS TP 108 Removes Short-Chain PFAS from Water

Specialty chemicals company LANXESS is introducing Lewatit MDS TP 108, a new ion exchange resin for removing short-chain fluorinated components (PFAS) from water. These PFAS, with three or fewer carbon atoms, are the smallest members of this substance class and are often the most difficult to remove during water treatment. The new product also enables users to save a considerable amount of material and disposal costs, because it lasts about twice as long as conventional ion exchange resins or alternative technologies such as activated carbon adsorption.

“With Lewatit MDS TP 108, we are setting new standards in water treatment and ideally complement our product portfolio for the removal of PFAS. At the same time, we help to protect water as a valuable resource,” says Dr Dirk Steinhilber, Application Technology Manager in the LANXESS Liquid Purification Technologies business unit.

LANXESS is a leading specialty chemicals company with sales of EUR 6.7 billion in 2023. The company currently has about 12,600 employees in 32 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. LANXESS is listed in the leading sustainability indices of the Dow Jones Sustainability Index (DJSI World and Europe).

Specialty chemicals company LANXESS is introducing Lewatit MDS TP 108, a new ion exchange resin for removing short-chain fluorinated components (PFAS) from water. These PFAS, with three or fewer carbon atoms, are the smallest members of this substance class and are often the most difficult to remove during water treatment. The new product also enables users to save a considerable amount of material and disposal costs, because it lasts about twice as long as conventional ion exchange resins or alternative technologies such as activated carbon adsorption. “With Lewatit MDS TP 108, we are setting new standards in water treatment and ideally complement our product portfolio for the removal of PFAS. At the same time, we help to protect water as a valuable resource,” says Dr Dirk Steinhilber, Application Technology Manager in the LANXESS Liquid Purification Technologies business unit. LANXESS is a leading specialty chemicals company with sales of EUR 6.7 billion in 2023. The company currently has about 12,600 employees in 32 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives and consumer protection products. LANXESS is listed in the leading sustainability indices of the Dow Jones Sustainability Index (DJSI World and Europe).

Next Story
Infrastructure Urban

ABB to Invest Rs 6.25 Billion to Expand India Manufacturing

ABB recently announced plans to invest approximately Rs 6.25 billion ($75 million) in India during 2026 to expand its manufacturing footprint and research and development capabilities. The investment follows more than $35 million spent in 2025 and reflects the company’s continued focus on strengthening its ‘local-for-local’ strategy in the country.The investment will support ABB’s Electrification, Motion and Automation businesses and expand manufacturing capacity for infrastructure sectors such as renewable energy, metro rail, data centres and industrial applications. Approximately 300..

Next Story
Equipment

Six WOLFF Cranes Handle 60,000 m³ Concrete for German Hospital

Six WOLFF tower cranes are playing a key role in constructing a new hospital complex in Memmingen, Germany, supporting large-scale material handling for the project. The facility is being built on a 7.7-hectare site and will feature six floors, around 480 beds and a gross floor area exceeding 75,000 sq m.Building shell works began recently in February 2025. One WOLFF 6531.12 Cross crane supported early site preparation before being dismantled in autumn 2025, while five remaining cranes continue operations. Over an average deployment period of 16 months, the cranes are expected to move approxim..

Next Story
Equipment

REC Funds Rs 115.6 Million CSR Support for Bihar Eye Hospital

REC recently committed Rs 115.6 million under its Corporate Social Responsibility (CSR) programme for the procurement of clinical and non-clinical equipment at Sankara Eye Hospital in Saharsa, Bihar. The initiative aims to strengthen healthcare infrastructure and improve access to specialised eye care services in the region.A Memorandum of Agreement (MoA) was recently signed between Pradeep Fellows, Executive Director (CSR), REC Limited, and Wg Cdr V. Shankar (Retd), Trustee and Executive Director of Sankara Eye Hospital, at the REC office in the SCOPE Complex, New Delhi.The support is expecte..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement